Market Tracker

12/19 10:10am ET
42.80
Real-Time Quote
 -0.35 / -0.81%
Today’s Change
28.14
Today|||52-Week Range
45.24
+30.93%
Year-to-Date

Today’s Trading

Previous close43.15
Today’s open43.03
Day’s range42.71 - 43.27
Volume811,897
Average volume (3 months)5,093,120
Market cap$20.6B
Dividend yield0.67%
Data as of 9:55am ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)+16.09%
Earnings growth (this year)+7.62%
Earnings growth (next 5 years)+10.60%
Revenue growth (last year)+5.19%
P/E ratio38.1
Price/Sales3.58
Price/Book21.88

Competitors

 Today’s
change
Today’s
% change
MYLMylan Inc+0.51+0.90%
PRGOPerrigo Company PLC+5.15+3.12%
VRTXVertex Pharmaceutica...+2.34+1.99%
BMRNBiomarin Pharmaceuti...+0.06+0.07%
Data as of 10:10am ET, 12/19/2014

Financials

Next reporting dateFebruary 10, 2015
EPS forecast (this quarter)$0.36
Annual revenue (last year)$4.6B
Annual profit (last year)$504.0M
Net profit margin11.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Juan Ramón Alaix
Chief Financial Officer &
Executive Vice President
Paul S. Herendeen
Corporate headquarters
Florham Park, New Jersey

Forecasts